Details for New Drug Application (NDA): 020363
✉ Email this page to a colleague
NDA 020363 describes FAMVIR, which is a drug marketed by Novartis and is included in one NDA. Additional details are available on the FAMVIR profile page.
The generic ingredient in FAMVIR is famciclovir. There is one drug master file entry for this compound. Nine suppliers are listed for this compound. Additional details are available on the famciclovir profile page.
The generic ingredient in FAMVIR is famciclovir. There is one drug master file entry for this compound. Nine suppliers are listed for this compound. Additional details are available on the famciclovir profile page.
Summary for 020363
| Tradename: | FAMVIR |
| Applicant: | Novartis |
| Ingredient: | famciclovir |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Apr 26, 1996 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Jun 29, 1994 | TE: | RLD: | Yes | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Dec 11, 1995 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
